The results link Glut1 repression and reduced glucose uptake to the anti-proliferative response of TGF-β1 and indicate that re-expression of Glut1 and increased glucose uptake during chronic TGF-β1 exposure allow breast cancer cells to develop a more stable EMT and proliferate, in parallel. Here, SLC2A1 is linked to breast carcinoma.